• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 022030 Product 002 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N022030 002 6858650 Jul 3, 2022 Y U - 913
N022030 002 7384980 May 11, 2019 Y Y U - 913
N022030 002 7807715 Jun 7, 2027 Y U - 913
N022030 002 7855230 May 11, 2019 U - 913
N022030 002 7985772 May 11, 2019 Y Y U - 913
N022030 002 8088398 Jun 7, 2027 Y U - 913
N022030 002 8338478 May 11, 2019 Y Y U - 913
N022030 002 8501723 Jun 7, 2027 Y

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N022030 002 NCE Oct 31, 2013


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through June 2014
Patent and Generic Drug Product Data Last Updated July 29, 2014

-
-